Differential diagnosis with hepcidin

Details Differential diagnosis with hepcidin Differential diagnosis with hepcidin

2004-10-22

2008-08-26

Gitomer, Ralph (Department: 1657)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving hydrolase

Reexamination Certificate

active

07416857

ABSTRACT:
The present invention concerns the use of hepcidin as a marker for detecting inflammatory chronic diseases and especially for a differential diagnosis to detect inflammatory chronic diseases and/or non-inflammatory chronic diseases. The present invention also concerns a method for detecting inflammatory chronic diseases, non-inflammatory chronic diseases and/or acute phase reactions comprising the determination of hepcidin.

REFERENCES:
patent: WO 98/04248 (1998-02-01), None
patent: WO 02/098444 (2002-12-01), None
patent: WO 03/025583 (2003-03-01), None
patent: WO 2004/058044 (2004-07-01), None
American Heart Association website, “Inflammation, Heart Disease and Stroke: The Role of C-Reactive Protein,” www.americanheart.org/presenter.jhtml?identifier=4648, Available Online: Jun. 5, 2003.
Centenary Cardiology website, “Homocysteine,” www.centenarycardiology.com/Conditions/Homocysteine.htm, Available Online: Dec. 27, 2002.
Sowers et al, “C-reactive Protein as a biomarker of emergent osteoarthritis,” (Osteoarthritis and Cartilage), vol. 10, pp. 595-601.
Dallalio et al, “Serum hepcidin in clinical specimens,” (British Journal of Haematology), 2003, vol. 122, pp. 996-1000.
Nemeth Elizabeta et al., 2003, “Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein”, Blood vol. 101(7).
Nicolas Gael et al., 2002, “The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation”, The Journal of Clin. Invest. vol. 110(7).
Weinstein David A et al., 2002, “Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease”, Blood vol. 100(10).
Roetto Antonella et al., 2003, “Mutant antimicrobial peptide hepcidin is associated with sever juvenile hemochromatosis”, Nature Genetics, vol. 33(1).
Okka Mehmet et al., 2002, “Plasma homocysteine level and uveitis in Behcet's disease”, The Israel Medical Assoc. J, vol. 4(11).
Theuma P et al., 2003, “Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis”, Curr. Diab. Reports, vol. 3(3).
Park et al., 2001, “Hepcidin, a urinary antimicrobial peptide synthesized in the liver”, J. Biol. Chem., vol. 276(11).
Nicolas et al., 2002, “Hepcidin, a new iron regulatory peptide”, Blood cells, Molecules and Diseases, vol. 29(3).
Weiss G et al., 1997, “Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-3”, J. Immunology, vol. 158(1).
T. Bjerregaard Larsen, et al., (2002) “Hyperhomocysteinaemia, Coagulation Pathway Activation and Thrombophilia in Patients with Inflammatory Bowel Disease”, Taylor & Francis Healthsciences, Scand J. Gastroenterol (1), pp. 1-6.
I. Morgenstern, et al., (2003), “Homocysteine, Cysteine, and Glutathione in Human Colonic Mucosa”, Digestive Diseases and Sciences, vol. 48(10), pp. 2083-2090.

Affiliated with

Also associated with

Rating

Differential diagnosis with hepcidin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Differential diagnosis with hepcidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Differential diagnosis with hepcidin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3995429